Vimarsana
Biggest News Aggregation in the World

Page 22 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

Rhythm Pharmaceuticals Announces New Employment Inducement - Vimarsana News

Rhythm Pharmaceuticals Announces New Employment Inducement

BOSTON, May 05, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on...

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN DIEGO, May 5, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® , a clinical-stage targeted oncology company, today announced that the company granted equity awards to 2 new employees... | June 17, 2023

Cellectis S A : PRELIMINARY NOTE - Form 6-K - Vimarsana News

Cellectis S A : PRELIMINARY NOTE - Form 6-K

PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the three-month period ended March 31, 2023, included herein, have been prepared in... | May 4, 2023

Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 04, 2023 -- Galera Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that... | May 4, 2023

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on April 28,... | April 28, 2023